documents: FDA-2008-D-0610-0012

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2008-D-0610-0012 FDA FDA-2008-D-0610 Guidance For Industry on Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic Other Guidance 2012-02-24T05:00:00Z 2012 2 2012-02-24T05:00:00Z   2012-02-24T15:11:42Z   0 0 0900006480fc051a

Links from other tables